… to changing lives through the creation of transformative RNA therapies for genetic eye diseases, will webcast a … its clinical stage pipeline programs and the Axiomer ® RNAediting platform. ProQR leadership will highlight key …
… to changing lives through the creation of transformative RNA therapies, today announced that Company management will … Medicines Symposium on June 29, 2022 as part of the RNAEditing track. The Company’s presentation will be webcast …
Axiomer™ ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program AX-0810 targeting NTCP for Cholestatic diseases Strengthened leadership with appointments of Chief Financial Officer and Chief
… company dedicated to changing lives through transformative RNA therapies, today announced several presentations … highlighting the Company’s proprietary Axiomer ® RNAediting technology platform at upcoming scientific and …
… company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer ™ RNAediting technology platform, today reported its financial …
